Pages that link to "Q80849728"
Jump to navigation
Jump to search
The following pages link to Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury (Q80849728):
Displaying 9 items.
- Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury (Q33581052) (← links)
- Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications (Q33876266) (← links)
- Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study (Q34513276) (← links)
- Moderate elevations in international normalized ratio should not lead to delays in neurosurgical intervention in patients with traumatic brain injury (Q35553092) (← links)
- Prothrombin complex concentrate versus fresh-frozen plasma for reversal of coagulopathy of trauma: is there a difference? (Q48866953) (← links)
- [Transfusion in neurosurgery] (Q79637572) (← links)
- Emerging treatments for traumatic brain injury (Q83402620) (← links)
- The role of recombinant activated factor VII in neuro- surgical and neurocritical patients (Q84534545) (← links)
- Factor VIIa administration in traumatic brain injury: an AAST-MITC propensity score analysis (Q88687080) (← links)